1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global IBS Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 IBS-D
        1.2.3 IBS-C
        1.2.4 IBS-M
    1.3 Market by Application
        1.3.1 Global IBS Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Research Laboratories
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global IBS Treatment Market Perspective (2017-2028)
    2.2 IBS Treatment Growth Trends by Region
        2.2.1 IBS Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 IBS Treatment Historic Market Size by Region (2017-2022)
        2.2.3 IBS Treatment Forecasted Market Size by Region (2023-2028)
    2.3 IBS Treatment Market Dynamics
        2.3.1 IBS Treatment Industry Trends
        2.3.2 IBS Treatment Market Drivers
        2.3.3 IBS Treatment Market Challenges
        2.3.4 IBS Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top IBS Treatment Players by Revenue
        3.1.1 Global Top IBS Treatment Players by Revenue (2017-2022)
        3.1.2 Global IBS Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global IBS Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by IBS Treatment Revenue
    3.4 Global IBS Treatment Market Concentration Ratio
        3.4.1 Global IBS Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by IBS Treatment Revenue in 2021
    3.5 IBS Treatment Key Players Head office and Area Served
    3.6 Key Players IBS Treatment Product Solution and Service
    3.7 Date of Enter into IBS Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 IBS Treatment Breakdown Data by Type
    4.1 Global IBS Treatment Historic Market Size by Type (2017-2022)
    4.2 Global IBS Treatment Forecasted Market Size by Type (2023-2028)
5 IBS Treatment Breakdown Data by Application
    5.1 Global IBS Treatment Historic Market Size by Application (2017-2022)
    5.2 Global IBS Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America IBS Treatment Market Size (2017-2028)
    6.2 North America IBS Treatment Market Size by Type
        6.2.1 North America IBS Treatment Market Size by Type (2017-2022)
        6.2.2 North America IBS Treatment Market Size by Type (2023-2028)
        6.2.3 North America IBS Treatment Market Share by Type (2017-2028)
    6.3 North America IBS Treatment Market Size by Application
        6.3.1 North America IBS Treatment Market Size by Application (2017-2022)
        6.3.2 North America IBS Treatment Market Size by Application (2023-2028)
        6.3.3 North America IBS Treatment Market Share by Application (2017-2028)
    6.4 North America IBS Treatment Market Size by Country
        6.4.1 North America IBS Treatment Market Size by Country (2017-2022)
        6.4.2 North America IBS Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe IBS Treatment Market Size (2017-2028)
    7.2 Europe IBS Treatment Market Size by Type
        7.2.1 Europe IBS Treatment Market Size by Type (2017-2022)
        7.2.2 Europe IBS Treatment Market Size by Type (2023-2028)
        7.2.3 Europe IBS Treatment Market Share by Type (2017-2028)
    7.3 Europe IBS Treatment Market Size by Application
        7.3.1 Europe IBS Treatment Market Size by Application (2017-2022)
        7.3.2 Europe IBS Treatment Market Size by Application (2023-2028)
        7.3.3 Europe IBS Treatment Market Share by Application (2017-2028)
    7.4 Europe IBS Treatment Market Size by Country
        7.4.1 Europe IBS Treatment Market Size by Country (2017-2022)
        7.4.2 Europe IBS Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific IBS Treatment Market Size (2017-2028)
    8.2 Asia-Pacific IBS Treatment Market Size by Type
        8.2.1 Asia-Pacific IBS Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific IBS Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific IBS Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific IBS Treatment Market Size by Application
        8.3.1 Asia-Pacific IBS Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific IBS Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific IBS Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific IBS Treatment Market Size by Region
        8.4.1 Asia-Pacific IBS Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific IBS Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America IBS Treatment Market Size (2017-2028)
    9.2 Latin America IBS Treatment Market Size by Type
        9.2.1 Latin America IBS Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America IBS Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America IBS Treatment Market Share by Type (2017-2028)
    9.3 Latin America IBS Treatment Market Size by Application
        9.3.1 Latin America IBS Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America IBS Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America IBS Treatment Market Share by Application (2017-2028)
    9.4 Latin America IBS Treatment Market Size by Country
        9.4.1 Latin America IBS Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America IBS Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa IBS Treatment Market Size (2017-2028)
    10.2 Middle East & Africa IBS Treatment Market Size by Type
        10.2.1 Middle East & Africa IBS Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa IBS Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa IBS Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa IBS Treatment Market Size by Application
        10.3.1 Middle East & Africa IBS Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa IBS Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa IBS Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa IBS Treatment Market Size by Country
        10.4.1 Middle East & Africa IBS Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa IBS Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Allergan (Ireland)
        11.1.1 Allergan (Ireland) Company Details
        11.1.2 Allergan (Ireland) Business Overview
        11.1.3 Allergan (Ireland) IBS Treatment Introduction
        11.1.4 Allergan (Ireland) Revenue in IBS Treatment Business (2017-2022)
        11.1.5 Allergan (Ireland) Recent Developments
    11.2 Sucampo Pharmaceuticals (U.S.)
        11.2.1 Sucampo Pharmaceuticals (U.S.) Company Details
        11.2.2 Sucampo Pharmaceuticals (U.S.) Business Overview
        11.2.3 Sucampo Pharmaceuticals (U.S.) IBS Treatment Introduction
        11.2.4 Sucampo Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2017-2022)
        11.2.5 Sucampo Pharmaceuticals (U.S.) Recent Developments
    11.3 Ironwood Pharmaceuticals (U.S.)
        11.3.1 Ironwood Pharmaceuticals (U.S.) Company Details
        11.3.2 Ironwood Pharmaceuticals (U.S.) Business Overview
        11.3.3 Ironwood Pharmaceuticals (U.S.) IBS Treatment Introduction
        11.3.4 Ironwood Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2017-2022)
        11.3.5 Ironwood Pharmaceuticals (U.S.) Recent Developments
    11.4 Astellas Pharma (Japan)
        11.4.1 Astellas Pharma (Japan) Company Details
        11.4.2 Astellas Pharma (Japan) Business Overview
        11.4.3 Astellas Pharma (Japan) IBS Treatment Introduction
        11.4.4 Astellas Pharma (Japan) Revenue in IBS Treatment Business (2017-2022)
        11.4.5 Astellas Pharma (Japan) Recent Developments
    11.5 Bausch Health
        11.5.1 Bausch Health Company Details
        11.5.2 Bausch Health Business Overview
        11.5.3 Bausch Health IBS Treatment Introduction
        11.5.4 Bausch Health Revenue in IBS Treatment Business (2017-2022)
        11.5.5 Bausch Health Recent Developments
    11.6 Abbott Laboratories (U.S.)
        11.6.1 Abbott Laboratories (U.S.) Company Details
        11.6.2 Abbott Laboratories (U.S.) Business Overview
        11.6.3 Abbott Laboratories (U.S.) IBS Treatment Introduction
        11.6.4 Abbott Laboratories (U.S.) Revenue in IBS Treatment Business (2017-2022)
        11.6.5 Abbott Laboratories (U.S.) Recent Developments
    11.7 Synergy Pharmaceuticals (U.S.)
        11.7.1 Synergy Pharmaceuticals (U.S.) Company Details
        11.7.2 Synergy Pharmaceuticals (U.S.) Business Overview
        11.7.3 Synergy Pharmaceuticals (U.S.) IBS Treatment Introduction
        11.7.4 Synergy Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2017-2022)
        11.7.5 Synergy Pharmaceuticals (U.S.) Recent Developments
    11.8 Ardelyx (U.S.)
        11.8.1 Ardelyx (U.S.) Company Details
        11.8.2 Ardelyx (U.S.) Business Overview
        11.8.3 Ardelyx (U.S.) IBS Treatment Introduction
        11.8.4 Ardelyx (U.S.) Revenue in IBS Treatment Business (2017-2022)
        11.8.5 Ardelyx (U.S.) Recent Developments
    11.9 Nestle (Switzerland)
        11.9.1 Nestle (Switzerland) Company Details
        11.9.2 Nestle (Switzerland) Business Overview
        11.9.3 Nestle (Switzerland) IBS Treatment Introduction
        11.9.4 Nestle (Switzerland) Revenue in IBS Treatment Business (2017-2022)
        11.9.5 Nestle (Switzerland) Recent Developments
    11.10 Sebela Pharmaceuticals (Ireland)
        11.10.1 Sebela Pharmaceuticals (Ireland) Company Details
        11.10.2 Sebela Pharmaceuticals (Ireland) Business Overview
        11.10.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Introduction
        11.10.4 Sebela Pharmaceuticals (Ireland) Revenue in IBS Treatment Business (2017-2022)
        11.10.5 Sebela Pharmaceuticals (Ireland) Recent Developments
    11.11 Probi (Sweden)
        11.11.1 Probi (Sweden) Company Details
        11.11.2 Probi (Sweden) Business Overview
        11.11.3 Probi (Sweden) IBS Treatment Introduction
        11.11.4 Probi (Sweden) Revenue in IBS Treatment Business (2017-2022)
        11.11.5 Probi (Sweden) Recent Developments
    11.12 Alfasigma USA (Italy)
        11.12.1 Alfasigma USA (Italy) Company Details
        11.12.2 Alfasigma USA (Italy) Business Overview
        11.12.3 Alfasigma USA (Italy) IBS Treatment Introduction
        11.12.4 Alfasigma USA (Italy) Revenue in IBS Treatment Business (2017-2022)
        11.12.5 Alfasigma USA (Italy) Recent Developments
    11.13 RedHill Biopharma (Israel)
        11.13.1 RedHill Biopharma (Israel) Company Details
        11.13.2 RedHill Biopharma (Israel) Business Overview
        11.13.3 RedHill Biopharma (Israel) IBS Treatment Introduction
        11.13.4 RedHill Biopharma (Israel) Revenue in IBS Treatment Business (2017-2022)
        11.13.5 RedHill Biopharma (Israel) Recent Developments
    11.14 AstraZeneca (U.K)
        11.14.1 AstraZeneca (U.K) Company Details
        11.14.2 AstraZeneca (U.K) Business Overview
        11.14.3 AstraZeneca (U.K) IBS Treatment Introduction
        11.14.4 AstraZeneca (U.K) Revenue in IBS Treatment Business (2017-2022)
        11.14.5 AstraZeneca (U.K) Recent Developments
    11.15 Ipsen (France)
        11.15.1 Ipsen (France) Company Details
        11.15.2 Ipsen (France) Business Overview
        11.15.3 Ipsen (France) IBS Treatment Introduction
        11.15.4 Ipsen (France) Revenue in IBS Treatment Business (2017-2022)
        11.15.5 Ipsen (France) Recent Developments
    11.16 Novartis (Switzerland)
        11.16.1 Novartis (Switzerland) Company Details
        11.16.2 Novartis (Switzerland) Business Overview
        11.16.3 Novartis (Switzerland) IBS Treatment Introduction
        11.16.4 Novartis (Switzerland) Revenue in IBS Treatment Business (2017-2022)
        11.16.5 Novartis (Switzerland) Recent Developments
    11.17 Takeda Pharmaceutical Company (Japan)
        11.17.1 Takeda Pharmaceutical Company (Japan) Company Details
        11.17.2 Takeda Pharmaceutical Company (Japan) Business Overview
        11.17.3 Takeda Pharmaceutical Company (Japan) IBS Treatment Introduction
        11.17.4 Takeda Pharmaceutical Company (Japan) Revenue in IBS Treatment Business (2017-2022)
        11.17.5 Takeda Pharmaceutical Company (Japan) Recent Developments
    11.18 Synthetic Biologics (U.S.)
        11.18.1 Synthetic Biologics (U.S.) Company Details
        11.18.2 Synthetic Biologics (U.S.) Business Overview
        11.18.3 Synthetic Biologics (U.S.) IBS Treatment Introduction
        11.18.4 Synthetic Biologics (U.S.) Revenue in IBS Treatment Business (2017-2022)
        11.18.5 Synthetic Biologics (U.S.) Recent Developments
    11.19 Protagonist Therapeutics (U.S.)
        11.19.1 Protagonist Therapeutics (U.S.) Company Details
        11.19.2 Protagonist Therapeutics (U.S.) Business Overview
        11.19.3 Protagonist Therapeutics (U.S.) IBS Treatment Introduction
        11.19.4 Protagonist Therapeutics (U.S.) Revenue in IBS Treatment Business (2017-2022)
        11.19.5 Protagonist Therapeutics (U.S.) Recent Developments
    11.20 Pfizer (U.S.)
        11.20.1 Pfizer (U.S.) Company Details
        11.20.2 Pfizer (U.S.) Business Overview
        11.20.3 Pfizer (U.S.) IBS Treatment Introduction
        11.20.4 Pfizer (U.S.) Revenue in IBS Treatment Business (2017-2022)
        11.20.5 Pfizer (U.S.) Recent Developments
    11.21 Lexicon Pharmaceuticals (U.S.)
        11.21.1 Lexicon Pharmaceuticals (U.S.) Company Details
        11.21.2 Lexicon Pharmaceuticals (U.S.) Business Overview
        11.21.3 Lexicon Pharmaceuticals (U.S.) IBS Treatment Introduction
        11.21.4 Lexicon Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2017-2022)
        11.21.5 Lexicon Pharmaceuticals (U.S.) Recent Developments
    11.22 Innovate Biopharmaceuticals (U.S.)
        11.22.1 Innovate Biopharmaceuticals (U.S.) Company Details
        11.22.2 Innovate Biopharmaceuticals (U.S.) Business Overview
        11.22.3 Innovate Biopharmaceuticals (U.S.) IBS Treatment Introduction
        11.22.4 Innovate Biopharmaceuticals (U.S.) Revenue in IBS Treatment Business (2017-2022)
        11.22.5 Innovate Biopharmaceuticals (U.S.) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global IBS Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of IBS-D
    Table 3. Key Players of IBS-C
    Table 4. Key Players of IBS-M
    Table 5. Global IBS Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global IBS Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global IBS Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global IBS Treatment Market Share by Region (2017-2022)
    Table 9. Global IBS Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global IBS Treatment Market Share by Region (2023-2028)
    Table 11. IBS Treatment Market Trends
    Table 12. IBS Treatment Market Drivers
    Table 13. IBS Treatment Market Challenges
    Table 14. IBS Treatment Market Restraints
    Table 15. Global IBS Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global IBS Treatment Revenue Share by Players (2017-2022)
    Table 17. Global Top IBS Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IBS Treatment as of 2021)
    Table 18. Ranking of Global Top IBS Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by IBS Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players IBS Treatment Product Solution and Service
    Table 22. Date of Enter into IBS Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global IBS Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global IBS Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global IBS Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global IBS Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global IBS Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global IBS Treatment Revenue Share by Application (2017-2022)
    Table 30. Global IBS Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global IBS Treatment Revenue Share by Application (2023-2028)
    Table 32. North America IBS Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America IBS Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America IBS Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America IBS Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America IBS Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America IBS Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe IBS Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe IBS Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe IBS Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe IBS Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe IBS Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe IBS Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific IBS Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific IBS Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific IBS Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific IBS Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific IBS Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific IBS Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America IBS Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America IBS Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America IBS Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America IBS Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America IBS Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America IBS Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa IBS Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa IBS Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa IBS Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa IBS Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa IBS Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa IBS Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Allergan (Ireland) Company Details
    Table 63. Allergan (Ireland) Business Overview
    Table 64. Allergan (Ireland) IBS Treatment Product
    Table 65. Allergan (Ireland) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 66. Allergan (Ireland) Recent Developments
    Table 67. Sucampo Pharmaceuticals (U.S.) Company Details
    Table 68. Sucampo Pharmaceuticals (U.S.) Business Overview
    Table 69. Sucampo Pharmaceuticals (U.S.) IBS Treatment Product
    Table 70. Sucampo Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 71. Sucampo Pharmaceuticals (U.S.) Recent Developments
    Table 72. Ironwood Pharmaceuticals (U.S.) Company Details
    Table 73. Ironwood Pharmaceuticals (U.S.) Business Overview
    Table 74. Ironwood Pharmaceuticals (U.S.) IBS Treatment Product
    Table 75. Ironwood Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 76. Ironwood Pharmaceuticals (U.S.) Recent Developments
    Table 77. Astellas Pharma (Japan) Company Details
    Table 78. Astellas Pharma (Japan) Business Overview
    Table 79. Astellas Pharma (Japan) IBS Treatment Product
    Table 80. Astellas Pharma (Japan) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 81. Astellas Pharma (Japan) Recent Developments
    Table 82. Bausch Health Company Details
    Table 83. Bausch Health Business Overview
    Table 84. Bausch Health IBS Treatment Product
    Table 85. Bausch Health Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 86. Bausch Health Recent Developments
    Table 87. Abbott Laboratories (U.S.) Company Details
    Table 88. Abbott Laboratories (U.S.) Business Overview
    Table 89. Abbott Laboratories (U.S.) IBS Treatment Product
    Table 90. Abbott Laboratories (U.S.) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 91. Abbott Laboratories (U.S.) Recent Developments
    Table 92. Synergy Pharmaceuticals (U.S.) Company Details
    Table 93. Synergy Pharmaceuticals (U.S.) Business Overview
    Table 94. Synergy Pharmaceuticals (U.S.) IBS Treatment Product
    Table 95. Synergy Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 96. Synergy Pharmaceuticals (U.S.) Recent Developments
    Table 97. Ardelyx (U.S.) Company Details
    Table 98. Ardelyx (U.S.) Business Overview
    Table 99. Ardelyx (U.S.) IBS Treatment Product
    Table 100. Ardelyx (U.S.) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 101. Ardelyx (U.S.) Recent Developments
    Table 102. Nestle (Switzerland) Company Details
    Table 103. Nestle (Switzerland) Business Overview
    Table 104. Nestle (Switzerland) IBS Treatment Product
    Table 105. Nestle (Switzerland) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 106. Nestle (Switzerland) Recent Developments
    Table 107. Sebela Pharmaceuticals (Ireland) Company Details
    Table 108. Sebela Pharmaceuticals (Ireland) Business Overview
    Table 109. Sebela Pharmaceuticals (Ireland) IBS Treatment Product
    Table 110. Sebela Pharmaceuticals (Ireland) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 111. Sebela Pharmaceuticals (Ireland) Recent Developments
    Table 112. Probi (Sweden) Company Details
    Table 113. Probi (Sweden) Business Overview
    Table 114. Probi (Sweden) IBS Treatment Product
    Table 115. Probi (Sweden) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 116. Probi (Sweden) Recent Developments
    Table 117. Alfasigma USA (Italy) Company Details
    Table 118. Alfasigma USA (Italy) Business Overview
    Table 119. Alfasigma USA (Italy) IBS Treatment Product
    Table 120. Alfasigma USA (Italy) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 121. Alfasigma USA (Italy) Recent Developments
    Table 122. RedHill Biopharma (Israel) Company Details
    Table 123. RedHill Biopharma (Israel) Business Overview
    Table 124. RedHill Biopharma (Israel) IBS Treatment Product
    Table 125. RedHill Biopharma (Israel) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 126. RedHill Biopharma (Israel) Recent Developments
    Table 127. AstraZeneca (U.K) Company Details
    Table 128. AstraZeneca (U.K) Business Overview
    Table 129. AstraZeneca (U.K) IBS Treatment Product
    Table 130. AstraZeneca (U.K) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 131. AstraZeneca (U.K) Recent Developments
    Table 132. Ipsen (France) Company Details
    Table 133. Ipsen (France) Business Overview
    Table 134. Ipsen (France) IBS Treatment Product
    Table 135. Ipsen (France) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 136. Ipsen (France) Recent Developments
    Table 137. Novartis (Switzerland) Company Details
    Table 138. Novartis (Switzerland) Business Overview
    Table 139. Novartis (Switzerland) IBS Treatment Product
    Table 140. Novartis (Switzerland) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 141. Novartis (Switzerland) Recent Developments
    Table 142. Takeda Pharmaceutical Company (Japan) Company Details
    Table 143. Takeda Pharmaceutical Company (Japan) Business Overview
    Table 144. Takeda Pharmaceutical Company (Japan) IBS Treatment Product
    Table 145. Takeda Pharmaceutical Company (Japan) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 146. Takeda Pharmaceutical Company (Japan) Recent Developments
    Table 147. Synthetic Biologics (U.S.) Company Details
    Table 148. Synthetic Biologics (U.S.) Business Overview
    Table 149. Synthetic Biologics (U.S.) IBS Treatment Product
    Table 150. Synthetic Biologics (U.S.) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 151. Synthetic Biologics (U.S.) Recent Developments
    Table 152. Protagonist Therapeutics (U.S.) Company Details
    Table 153. Protagonist Therapeutics (U.S.) Business Overview
    Table 154. Protagonist Therapeutics (U.S.) IBS Treatment Product
    Table 155. Protagonist Therapeutics (U.S.) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 156. Protagonist Therapeutics (U.S.) Recent Developments
    Table 157. Pfizer (U.S.) Company Details
    Table 158. Pfizer (U.S.) Business Overview
    Table 159. Pfizer (U.S.) IBS Treatment Product
    Table 160. Pfizer (U.S.) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 161. Pfizer (U.S.) Recent Developments
    Table 162. Lexicon Pharmaceuticals (U.S.) Company Details
    Table 163. Lexicon Pharmaceuticals (U.S.) Business Overview
    Table 164. Lexicon Pharmaceuticals (U.S.) IBS Treatment Product
    Table 165. Lexicon Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 166. Lexicon Pharmaceuticals (U.S.) Recent Developments
    Table 167. Innovate Biopharmaceuticals (U.S.) Company Details
    Table 168. Innovate Biopharmaceuticals (U.S.) Business Overview
    Table 169. Innovate Biopharmaceuticals (U.S.) IBS Treatment Product
    Table 170. Innovate Biopharmaceuticals (U.S.) Revenue in IBS Treatment Business (2017-2022) & (US$ Million)
    Table 171. Innovate Biopharmaceuticals (U.S.) Recent Developments
    Table 172. Research Programs/Design for This Report
    Table 173. Key Data Information from Secondary Sources
    Table 174. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global IBS Treatment Market Share by Type: 2021 VS 2028
    Figure 2. IBS-D Features
    Figure 3. IBS-C Features
    Figure 4. IBS-M Features
    Figure 5. Global IBS Treatment Market Share by Application: 2021 VS 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Research Laboratories Case Studies
    Figure 9. IBS Treatment Report Years Considered
    Figure 10. Global IBS Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global IBS Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global IBS Treatment Market Share by Region: 2021 VS 2028
    Figure 13. Global IBS Treatment Market Share by Players in 2021
    Figure 14. Global Top IBS Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IBS Treatment as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by IBS Treatment Revenue in 2021
    Figure 16. North America IBS Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America IBS Treatment Market Size Market Share by Type (2017-2028)
    Figure 18. North America IBS Treatment Market Size Market Share by Application (2017-2028)
    Figure 19. North America IBS Treatment Market Size Share by Country (2017-2028)
    Figure 20. United States IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe IBS Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe IBS Treatment Market Size Market Share by Type (2017-2028)
    Figure 24. Europe IBS Treatment Market Size Market Share by Application (2017-2028)
    Figure 25. Europe IBS Treatment Market Size Share by Country (2017-2028)
    Figure 26. Germany IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific IBS Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific IBS Treatment Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific IBS Treatment Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific IBS Treatment Market Size Share by Region (2017-2028)
    Figure 36. China IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America IBS Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America IBS Treatment Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America IBS Treatment Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America IBS Treatment Market Size Share by Country (2017-2028)
    Figure 46. Mexico IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa IBS Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa IBS Treatment Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa IBS Treatment Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa IBS Treatment Market Size Share by Country (2017-2028)
    Figure 52. Turkey IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE IBS Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Allergan (Ireland) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 56. Sucampo Pharmaceuticals (U.S.) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 57. Ironwood Pharmaceuticals (U.S.) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 58. Astellas Pharma (Japan) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 59. Bausch Health Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 60. Abbott Laboratories (U.S.) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 61. Synergy Pharmaceuticals (U.S.) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 62. Ardelyx (U.S.) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 63. Nestle (Switzerland) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 64. Sebela Pharmaceuticals (Ireland) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 65. Probi (Sweden) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 66. Alfasigma USA (Italy) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 67. RedHill Biopharma (Israel) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 68. AstraZeneca (U.K) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 69. Ipsen (France) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 70. Novartis (Switzerland) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 71. Takeda Pharmaceutical Company (Japan) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 72. Synthetic Biologics (U.S.) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 73. Protagonist Therapeutics (U.S.) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 74. Pfizer (U.S.) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 75. Lexicon Pharmaceuticals (U.S.) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 76. Innovate Biopharmaceuticals (U.S.) Revenue Growth Rate in IBS Treatment Business (2017-2022)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed